Extrapolating Prognostic Factors of Primary Curative Resection to Postresection Recurrences Hepatocellular Carcinoma Treatable by Radiofrequency Ablation

Table 5

Baseline characteristics between the short time to recurrence after curative resection group and the long time to recurrence after curative resection group.

	Variables	Short time to recurrence after curative resection ()	Long time to recurrence after curative resection ()	value
Factors of primary curative resection	Gender, male/female	69/9	127/30	0.098^2
	Age (years)			0.120^1
	Hepatitis, yes/no	72/6	142/15	0.419^2
	Cirrhosis, yes/no	17/61	37/120	0.449^1
	Tumor size (cm)			0.874^1
	Tumor number, multiple/single	17/61	34/123	0.553^2
	Tumor differentiation (>II), yes/no	28/50	36/121	0.027^2
	Microvascular invasion, yes/no	25/53	32/125	0.029^2
	Encapsulation invasion, yes/no	2/76	5/152	0.574^2
	Star lesion, yes/no	2/76	4/153	0.649^2
	Postoperative adjuvant TACE, yes/no	26/52	43/114	0.214^2
Features before RFA	TB (>17.1 μmol/l), yes/no	3/75	27/130	0.452^2
	ALT (>50 IU/l), yes/no	12/66	20/137	0.578^2
	PT (>14 s), yes/no	5/73	9/148	0.836^2
	Albumin (≤3.5 g/dl), yes/no	2/76	10/147	0.212^2
	GGT (>50 IU/l), yes/no	36/42	59/98	0.207^2
	AFP (>20 ng/ml), yes/no	26/52	54/103	0.872^2
	Tumor size (cm)			0.470^1
	Tumor number, multiple/single	14/64	22/135	0.272^2

Data are expressed as the number or . RFA: radiofrequency ablation; TB: total bilirubin; ALT: alanine aminotransferase; PT: prothrombin time; GGT: γ-glutamyltranspeptidase; AFP: alpha-fetoprotein; ¹unpaired t test; ²Fisher’s exact test or test.